Rajani Shrestha
Overview
Explore the profile of Rajani Shrestha including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
382
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bhandari T, Laghu U, Ratna P, Shrestha R
Int J Microbiol
. 2022 Nov;
2022:1508473.
PMID: 36406905
is one of the most pathogenic organisms that cause gastritis, peptic ulcer, gastric adenocarcinoma, and mucosa-associated lymphoid tissue (MALT) lymphoma in humans. The main aim of this study was to...
2.
Bhatta D, Koirala S, Baral A, Amatya N, Parajuli S, Shrestha R, et al.
Can J Infect Dis Med Microbiol
. 2022 May;
2022:1023241.
PMID: 35637744
Background: Bacterial contamination in intensive care units is an important risk factor associated with increasing incidences of nosocomial infections. This study was conducted to study the bacterial colonization on commonly...
3.
Bhatta D, Subramanya S, Hamal D, Shrestha R, Gauchan E, Basnet S, et al.
Antimicrob Resist Infect Control
. 2021 Jan;
10(1):26.
PMID: 33516271
Background: Intensive care units (ICU) are essential healthcare facility for life threatening conditions. Bacterial contamination of objects/instruments in ICU is an important source of nosocomial infections. This study is aimed...
4.
Zhang J, Belbachir N, Zhang T, Liu Y, Shrestha R, Wu J
Stem Cell Reports
. 2020 Dec;
16(1):168-181.
PMID: 33338435
Burgeoning applications of human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) in disease modeling, regenerative medicine, and drug screening have broadened the usage of hiPSC-CMs and entailed their long-term storage. Cryopreservation...
5.
Tian L, Oikonomopoulos A, Liu C, Kitani T, Shrestha R, Chen C, et al.
Circulation
. 2020 Apr;
141(14):1208-1210.
PMID: 32250699
No abstract available.
6.
Lau E, Han Y, Williams D, Thomas C, Shrestha R, Wu J, et al.
Cell Rep
. 2019 Dec;
29(11):3751-3765.e5.
PMID: 31825849
The protein-level translational status and function of many alternative splicing events remain poorly understood. We use an RNA sequencing (RNA-seq)-guided proteomics method to identify protein alternative splicing isoforms in the...
7.
Kafle A, Adhikari B, Shrestha R, Ranjit N
J Nepal Health Res Counc
. 2019 May;
17(1):90-93.
PMID: 31110384
Background: Right hepatic duct, formed by the confluence of the anterior and posterior right sectorial ducts, joins left hepatic duct to form common hepatic duct. This fashion of confluence does...
8.
Lam C, Tian L, Belbachir N, Wnorowski A, Shrestha R, Ma N, et al.
Circ Res
. 2019 May;
125(2):212-222.
PMID: 31079550
Rationale: Calcium channel blockers (CCBs) are an important class of drugs in managing cardiovascular diseases. Patients usually rely on these medications for the remainder of their lives after diagnosis. Although...
9.
Seeger T, Shrestha R, Lam C, Chen C, McKeithan W, Lau E, et al.
Circulation
. 2018 Dec;
139(6):799-811.
PMID: 30586709
Background: Hypertrophic cardiomyopathy (HCM) is frequently caused by mutations in myosin-binding protein C3 ( MYBPC3) resulting in a premature termination codon (PTC). The underlying mechanisms of how PTC mutations in...
10.
Bhatta D, Hamal D, Shrestha R, Subramanya S, Baral N, Singh R, et al.
Antimicrob Resist Infect Control
. 2018 Aug;
7:97.
PMID: 30128144
Background: Objects frequently touched by patients and healthcare workers in hospitals harbor potential pathogens and may act as source of infectious agents. This study aimed to determine the bacterial contamination...